-
Mashup Score: 0Hope on the Horizon: 2 Food Allergy Breakthroughs in 2024 - 7 hour(s) ago
Kim, Sindher, Huffaker spoke with HCPLive about some of the year’s most important developments in the food allergy space, namely the approvals of omalizumab and neffy.
Source: www.hcplive.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 0Hope on the Horizon: 2 Food Allergy Breakthroughs in 2024 - 2 day(s) ago
Kim, Sindher, Huffaker spoke with HCPLive about some of the year’s most important developments in the food allergy space, namely the approvals of omalizumab and neffy.
Source: www.hcplive.comCategories: General Medicine News, General NewsTweet-
The FDA approvals of #omalizumab (Xolair) and epinephrine nasal spray (#neffy) have made 2024 a big year in the food allergy space. We spoke with 3 allergists about the importance and impact of these approvals. View their responses here: https://t.co/uWqJOhRQzX #FoodAllergy
-
The FDA approvals of #omalizumab (Xolair) and epinephrine nasal spray (#neffy) have made 2024 a big year in the food allergy space. We spoke with 3 allergists about the importance and impact of these approvals. View their responses here: https://t.co/uWqJOhRQzX #FoodAllergy